Description
Blood Screening and Typing Markets
Blood Screening and Typing Markets analyzes the infectious disease blood typing and the infectious disease blood screening opportunities, including complete revenue estimates of the blood screening and typing markets: global blood typing and screening revenues, 2015 and 2020 (ABO grouping, immunoassay screen, NAT screen); selected blood typing innovations; blood typing by country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%); infectious disease blood typing market portion by manufacturer; immunoassay testing market by country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%); selected new blood screening immunoassays; NAT blood screening market by country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%); Selected new blood screen NAT tests and systems; and infectious disease blood screening test market share by company.
Blood typing and testing represents the cornerstone of ensuring that transfused blood is safe for the recipient and free of disease. The report provides a complete review of the blood screening and typing markets, discussing risk of contamination; viral inactivation by procedure; basic blood types; blood transfusion compatibility; PCR-based screening tests licensed by CBER; comparison of direct and indirect ELISA tests; laboratory screening of blood donations for transfusion-transmissible infections, number of countries; blood component usage; pathogens commonly tested in donated blood units; selected pathogen screening innovations.
Grifols and Roche Diagnostics are among the manufacturers discussed in the report’s competitive analysis.
Table of Contents
ONE: EXECUTIVE SUMMARY
Blood Screening
Blood Typing
The Market for Blood Testing and Typing
TWO: INTRODUCTION
Reducing Blood Typing Errors
Improving Donor Screening
Improving Viral Screening
Increasing Repeat Donation Rates
Enhancing Viral Inactivation Processes
Increasing Voluntary Donation
Preventing Bacterial Infections
Biovigilance
Other Safety Precautions
Blood Typing
Methods of Blood Typing
Blood Testing
Nucleic Acid Amplification Testing (NAT)
CBER Licensed NAT Screening Tests
Polymerase Chain Reaction (PCR) Amplification
CBER Licensed PCR Screening Tests
Immunoassay
Enzyme-Linked Immunosorbent Assay
Costs and Other Barriers
Blood Storage
Blood Transfusions
Blood Pathogen Screening
THREE: MARKET ANALYSIS
Blood Banking Gets a Shakeup
Blood Typing
Blood Grouping and Typing
Immunoassays
Nucleic Acid Testing (NAT)
Market Share in Blood Testing
FOUR: COMPANY PROFILES
Abbott Diagnostics
AXO Science
Beckman Coulter
bioMérieux Inc
Cerus Corporation
DiaSorin S.p.A
Grifols
Blood Transfusion Novartis Business
International Programs
Haemonetics Corporation
Hologic, Inc.
Product News
The Gen-Probe Business
Panther System
Blood Bank
Quest Contract
Immucor, Inc.
Immunetics Inc.
Ortho Clinical Diagnostics
Quotient Limited
Roche Diagnostics
Terumo BCT
Verax Biomedical Inc.
LIST OF EXHIBITS
ONE: EXECUTIVE SUMMARY
Figure 1-1: The Market for Blood Testing and Typing, 2015 and 2020
TWO: INTRODUCTION
Table 2-1: Risk of Contamination
Table 2-2: Viral Inactivation by Procedure
Table 2-3: Basic Blood Types
Table 2-4: Blood Transfusion Compatibility
Table 2-5: PCR-Based Screening Tests Licensed by CBER
Table 2-6: Comparison of Direct and Indirect ELISA Tests
Table 2-7: Laboratory Screening of Blood Donations for Transfusion-Transmissible Infections, Number of Countries
Table 2-8: Blood Component Usage
Table 2-9: Pathogens Commonly Tested in Donated Blood Units
Table 2-10: Selected Pathogen Screening Innovations
THREE: MARKET ANALYSIS
Table 3-1: Worldwide Blood Typing and Screening Sales, 2015 and 2020 (ABO Grouping, Immunoassay Screen, NAT Screen)
Figure 3-1: Worldwide Blood Typing and Screening Sales, 2015 and 2020 (ABO Grouping, Immunoassay Screen, NAT Screen)
Table 3-2: Selected Blood Typing Innovations
Figure 3-2: Blood Typing by Country, 2015 (United States, Italy, Germany, UK,
France, Spain, Japan, China, Other Asia, Latin America, ROW) (%)
Table 3-3: Infectious Disease Blood Typing Market Share by Company
Figure 3-3: Immunoassay Testing Market by Country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%)
Table 3-4: Selected New Blood Screening Immunoassays
Figure 3-4: NAT Blood Screening Market by Country, 2015 (United States, Italy, Germany, UK, France, Spain, Japan, China, Other Asia, Latin America, ROW) (%)
Table 3-5: Selected New Blood Screen NAT Tests and Systems
Table 3-6: Infectious Disease Blood Screening Test Market Share by Company
